Welcome to our dedicated page for BlackRock Capital Allocation Term ord SEC filings (Ticker: BCAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
blackrock's business is investing on behalf of our clients, from large institutions to parents and grandparents, doctors and teachers who entrust their savings to us. we work only for our clients—period. our promise is to offer them the clearest thinking about what to do with their money and the products and services they need to secure a better financial future. that's why investors of all kinds have made us the world’s largest asset manager, entrusting us with trillions of dollars, and it’s why companies, institutions and global governments come to us for help meeting their biggest financial challenges. important disclosures: http://www.blackrock.com/corporate/en-us/compliance/social-media-guidelinesSaba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein jointly filed Amendment No. 21 to their Schedule 13D on BlackRock Capital Allocation Term Trust (ticker BCAT).
- Ownership disclosed: 5,352,474 – 5,352,475 common shares, equal to 5.11 % of the 104,775,271 shares outstanding as of 5/19/25.
- Voting/Dispositive power: 0 sole; full power is shared among the reporting persons.
- Cost basis: approximately $78.4 million in aggregate consideration, funded with investor capital and ordinary-course margin borrowings.
- Transaction window: open-market purchases between 7/14/25 and 7/24/25 prompted the filing.
- Purpose of transaction: “Not Applicable”; no specific strategic intentions or agreements were disclosed (Items 4 & 6).
The filing converts the group from passive (13G) to active (13D) status and updates Items 3, 5 and 7. No criminal or civil proceedings are reported against the filers, and signature authority is provided by General Counsel Michael D’Angelo.
Saba Capital Management, L.P., its general partner Saba Capital Management GP, LLC, and founder Boaz R. Weinstein have filed Amendment No. 19 to Schedule 13D disclosing a materially higher position in BlackRock Capital Allocation Term Trust (BCAT). As of the event date 27 June 2025, the group beneficially owns 7,802,473–7,802,474 common shares, equal to 7.45 % of BCAT’s outstanding 104,775,271 shares. The holding is entirely shared voting and dispositive power; no shares are held with sole authority.
The filing indicates that approximately $114.3 million of investor capital and margin borrowings were deployed to build the position. Items 3, 5 and 7 of the original 13D have been amended, primarily to update the source of funds and current ownership. The “Purpose of Transaction” section remains “Not Applicable,” meaning the group has not publicly outlined an activist plan at this stage. Nonetheless, Saba’s track record of pushing for tender offers, buy-backs and governance changes in closed-end funds suggests the 7.45 % stake could become influential if the position grows toward the 10 % threshold that often triggers additional disclosure and leverage.
- Reporting persons: Saba Capital Management, L.P.; Saba Capital Management GP, LLC; Boaz R. Weinstein.
- Event date: 27 Jun 2025; filing signed 30 Jun 2025.
- Shares owned: 7,802,473–7,802,474 (shared power).
- Ownership percentage: 7.45 % of BCAT common shares.
- Total cost basis disclosed: approx. $114.3 million.
FAQ
What is the current stock price of BlackRock Capital Allocation Term ord (BCAT)?
What is the market cap of BlackRock Capital Allocation Term ord (BCAT)?
